Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

NCT02515097 PHASE3 COMPLETED Results posted

This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).

Details

Lead sponsor	Bausch Health Americas, Inc.
Phase	PHASE3
Status	COMPLETED
Enrolment	213
Start date	Thu Nov 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Plaque Psoriasis

Interventions

• IDP-122 Lotion
• IDP-122 Vehicle Lotion

Countries

United States